Biophysics
Sygnature Discovery
JUNE 17, 2024
Biophysics in Drug Discovery: A Sygnature Approach Our key biophysics leaders alone possess over 50 years of combined experience in drug discovery, spanning CRO, pharmaceutical, and biotech sectors, and applied across various target classes and therapeutic modalities. Nucleic Acid Targets: Focusing on specific interactions and functions.
Let's personalize your content